共 44 条
[1]
Bray F, Laversanne M, Sung H, Et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 74, pp. 229-263, (2024)
[2]
Harada K, Yamamoto S, Kato K., Pembrolizumab for the treatment of advanced esophageal cancer, Future Oncol, 18, pp. 2311-2319, (2022)
[3]
Huang FL, Yu SJ., Esophageal cancer: Risk factors, genetic association, and treatment, Asian J Surg, 41, pp. 210-215, (2018)
[4]
Uhlenhopp DJ, Then EO, Sunkara T, Et al., Epidemiology of esophageal cancer: update in global trends, etiology and risk factors, Clin J Gastroenterol, 13, pp. 1010-1021, (2020)
[5]
Degterev A, Huang Z, Boyce M, Et al., Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury, Nat Chem Biol, 1, pp. 112-119, (2005)
[6]
Yan J, Wan P, Choksi S, Et al., Necroptosis and tumor progression, Trends Cancer, 8, pp. 21-27, (2022)
[7]
Yin J, Yu Y, Huang X, Et al., Necroptosis in immunity, tissue homeostasis, and cancer, Curr Opin Immunol, 89, (2024)
[8]
Koo GB, Morgan MJ, Lee DG, Et al., Methylationdependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics, Cell Res, 25, pp. 707-725, (2015)
[9]
Seifert L, Werba G, Tiwari S, Et al., The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincleinduced immune suppression, Nature, 532, pp. 245-249, (2016)
[10]
Jiao D, Cai Z, Choksi S, Et al., Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis, Cell Res, 28, pp. 868-870, (2018)